IDiyas

For the Inventor, By the Inventor

Ibaraki, Japan

Yuuki Komatu

USPTO Granted Patents = 13

Average Co-Inventor Count = 9.1

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Ibaraki, JP (1988 - 1997)
  • Ibaraki Prefecture, JP (1996 - 1998)

Company Filing History:

goldMedal13 out of 677 
 
Eisai Company, Limited
 patents

Years Active: 1988-1998

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5741902 - 7-acyl-3-(substituted carbamoyloxy) cephem compounds and process for (1998-04-21),
2. 5604217 - 7-acyl-3-(substituted carbamoyloxy) cephem compounds and process for (1997-02-18),
3. 5587473 - 7-acyl-3-(substituted carbamoyloxy) cephem compounds and process for (1996-12-24),
4. 5563265 - 7-acyl-3-(substituted carbamoyloxy) cephem compounds (1996-10-08),
5. 5559225 - 7-acyl-3-(substituted carbamoyloxy) cephem compound (1996-09-24),
6. 5373000 - 7Beta-(thiadiazolyl)-2-iminoacetamido-3cephem compounds (1994-12-13),
7. 5151417 - 3-substituted vinyl cephalosporin derivatives (1992-09-29),
8. 5128465 - Process for the preparation of cephem derivatives and intermediates (1992-07-07),
9. 5089491 - 3-propenylcephem derivative (1992-02-18),
10. 5006649 - 3-propenylcephem derivative (1991-04-09),
11. 4929612 - Thiadiazolylacetamide cephem derivatives (1990-05-29),
12. 4921850 - 3-propenylcephem derivative (1990-05-01),
13. 4721788 - 4-cyanopiperidine derivatives (1988-01-26),

Title: The Innovations of Yuuki Komatu: A Trailblazer in Antibacterial Compounds

Introduction: Yuuki Komatu, a brilliant inventor hailing from Ibaraki, Japan, has made substantial contributions to the field of pharmaceuticals with his groundbreaking work in antibiotic compounds. With a total of 13 patents to his name, Komatu's dedication to innovation is evident in his latest patents for 7-acyl-3-(substituted carbamoyloxy) cephem compounds.

Latest Patents: Komatu's recent patents focus on 7-acyl-3-substituted carbamoyloxy cephem compounds, showcasing his expertise in developing novel antibacterial agents. These compounds, represented by complex chemical formulas, demonstrate his adeptness in creating pharmaceutical solutions to combat bacterial infections effectively.

Career Highlights: Yuuki Komatu is currently associated with Eisai Company, Limited, a renowned pharmaceutical company known for its innovative drug development. Within Eisai, Komatu has spearheaded projects aimed at enhancing antibacterial treatments, displaying his knack for merging science with practical applications in the pharmaceutical industry.

Collaborations: In his professional journey, Komatu has collaborated with esteemed colleagues such as Isao Sugiyama and Shigeto Negi. Together, they have synergized their expertise to push the boundaries of antibiotic research, fostering a culture of innovation and excellence within Eisai Company, Limited.

Conclusion: Yuuki Komatu's unwavering commitment to developing cutting-edge antibacterial compounds underscores his status as a pioneer in the realm of pharmaceutical innovations. His remarkable patents and collaborative efforts highlight his exceptional talent and dedication to advancing the field of medicine through inventive solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…